Singapore markets closed

NeuBase Therapeutics, Inc. (NBSE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.0200+0.0600 (+6.25%)
At close: 04:00PM EDT
1.0600 +0.04 (+3.92%)
After hours: 06:12PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2021
30/09/2020
30/09/2019
30/09/2018
Total revenue
0
0
0
0
0
Operating expenses
Research development
20,374
14,363
6,946
17,241
4,319
Selling general and administrative
12,869
12,202
10,123
9,096
3,634
Total operating expenses
33,243
26,565
17,069
26,336
9,078
Operating income or loss
-33,243
-26,565
-17,069
-26,336
-9,078
Interest expense
34.668
32.33
7.686
128.951
-
Total other income/expenses net
-204.627
1,176
-307.528
-492.889
-4,233
Income before tax
-33,474
-25,409
-17,385
-26,958
-13,237
Income from continuing operations
-33,474
-25,409
-17,385
-26,958
-13,237
Net income
-33,474
-25,409
-17,385
-26,958
-13,237
Net income available to common shareholders
-33,474
-25,409
-17,385
-26,958
-13,237
Basic EPS
-
-0.93
-0.89
-3.26
-4.60
Diluted EPS
-
-0.93
-0.89
-3.26
-4.60
Basic average shares
-
27,306
19,620
8,272
2,820
Diluted average shares
-
27,306
19,620
8,272
2,820
EBITDA
-
-24,974
-17,096
-26,701
-7,954